Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03135210 · ClinicalTrials.gov registry record · NA
Leg Exercise During ECMO
A NA study of Refractory Respiratory Failure, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT03135210: Completed NA study of Refractory Respiratory Failure, sponsored by University of Minnesota.
NCT03135210 is a NA study of Refractory Respiratory Failure that has completed, run by University of Minnesota. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03135210, a NA study of Refractory Respiratory Failure, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients undergoing extracorporeal membrane oxygenation (ECMO) are at high risk for deconditioning and functional decline. The primary aim of this study is to assess the functional impact of leg exercise during the pre-ambulation phase in patients undergoing ECMO.
Primary Outcome
Time to ambulation is measured as the number of days required for the participant to regain the ability to walk without the need for any kind of assistance. The unit of measure is days.
Conditions Studied
Interventions
- OTHER Open-Chain Leg Exercise
- DEVICE Closed-Chain Leg Exercise
Study Locations (1)
Minnesota
- University of Minnesota Medical Center, Fairview - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-11-13 |
| Est. Completion | 2020-02-01 |
| Phase | NA |
What the finished NCT03135210 record still lists
NCT03135210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Refractory Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Open-Chain Leg Exercise is the first listed.
NCT03135210 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03135210 about?
NCT03135210 is a clinical study titled "Leg Exercise During ECMO". Patients undergoing extracorporeal membrane oxygenation (ECMO) are at high risk for deconditioning and functional decline. The primary aim of this study is to assess the functional impact of leg exercise during the pre-ambulation phase in patients undergoing ECMO.
What is the current status of trial NCT03135210?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2017-11-13. Estimated completion is 2020-02-01.
What conditions does trial NCT03135210 study?
This clinical trial studies the following conditions: Refractory Respiratory Failure.
What interventions are being tested in trial NCT03135210?
The interventions under investigation include: Open-Chain Leg Exercise (OTHER), Closed-Chain Leg Exercise (DEVICE).
Who is sponsoring clinical trial NCT03135210?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03135210 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03135210's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI